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Abstract
Metabolic coherence (MC) is a network-based approach to dimensionality reduction that can be used, for example, to inter-
pret the joint expression of genes linked to human metabolism. Computationally, the derivation of ‘transcriptomic’ MC 
involves mapping of an individual gene expression profile onto a gene-centric network derived beforehand from a metabolic 
network (currently Recon2), followed by the determination of the connectivity of a particular, profile-specific subnetwork. 
The biological significance of MC has been exemplified previously in the context of human inflammatory bowel disease, 
among others, but the genetic architecture of this quantitative cellular trait is still unclear. Therefore, we performed a 
genome-wide association study (GWAS) of MC in the 1000 Genomes/ GEUVADIS data (n = 457) and identified a solitary 
genome-wide significant association with single nucleotide polymorphisms (SNPs) in the intronic region of the cadherin 18 
(CDH18) gene on chromosome 5 (lead SNP: rs11744487, p = 1.2 × 10− 8). Cadherin 18 is a transmembrane protein involved 
in human neural development and cell-to-cell signaling. Notably, genetic variation at the CDH18 locus has been associated 
with metabolic syndrome-related traits before. Replication of our genome-wide significant GWAS result was successful in 
another population study from the Netherlands (BIOS, n = 2661; lead SNP), but failed in two additional studies (KORA, 
Germany, n = 711; GENOA, USA, n = 411). Besides sample size issues, we surmise that these discrepant findings may be 
attributable to technical differences. While 1000 Genomes/GEUVADIS and BIOS gene expression profiles were generated 
by RNA sequencing, the KORA and GENOA data were microarray-based. In addition to providing first evidence for a link 
between regional genetic variation and a metabolism-related characteristic of human transcriptomes, our findings highlight 
the benefit of adopting a systems biology-oriented approach to molecular data analysis.
Introduction
Over the last 15 years, the development of high-throughput 
molecular technologies has greatly improved the scope and 
prospects of biological and biomedical research. At the same 
time, however, this newly acquired ability to characterize 
biological entities in their entirety and in great detail has led 
to an increased need for more efficient and more powerful 
approaches to data analysis. Omics technologies such as next 
generation DNA sequencing, in particular, generate large 
amounts of high-dimensional data per study subject that 
need to be processed and contextualized further to facilitate 
their biological interpretation.
One way to meet this challenge is dimensionality reduc-
tion, which means transforming the original data into data 
of much lower complexity but at the same time preserving 
as much as possible, or necessary, of the important informa-
tion included in the original data. However, classical dimen-
sionality reduction techniques such as principal component 
analysis and multi-dimensional scaling are ‘agnostic’ in the 
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sense that they do not take the specificities of the data into 
account and, hence, hold a risk of losing critical informa-
tion. To some extent, these shortcomings may be overcome 
by contextualizing the data with external knowledge. In 
biology, in particular, comprehensive systemic information 
is often available, for example, in the form of biological 
networks that formally represent complex biochemical pro-
cesses. In fact, using this type of information to lift the curse 
of dimensionality, in our view, represents an essential aspect 
of systems biology.
Mapping experimental data onto a network allows the 
resulting network properties, including connectivity and 
vertex separation (Bonchev and Buck 2005), to be used as 
one-dimensional proxies of the original data. Along these 
lines, the concept of metabolic network coherence (MC) 
was introduced by Sonnenschein et al. (2011) to contextual-
ize molecular data with a rich model of human metabolism 
(Fig. 1), currently Recon2 (Thiele et al. 2013). Since human 
diseases are often associated with metabolic disturbance, 
basing the dimensionality reduction of molecular data from 
a clinical context upon the Recon2 network may greatly 
facilitate a systems-orientated understanding of the biologi-
cal processes involved in these conditions.
At the network level, Recon2 is a bipartite graph compris-
ing metabolite and reaction nodes. Following Sonnenschein 
et al. (2011), Recon2 can be converted into a gene-centric 
network by consideration of the underlying gene-reaction 
associations. More specifically, two genes are connected by 
an edge in the resulting network if the reactions associated 
with these genes share a common metabolite (Fig. 1). To 
avoid implausibly short distances in the gene-centric net-
work, however, the most highly connected metabolites (e.g., 
ATP and other ‘currency metabolites’) are removed from the 
original network prior to its projection onto the gene nodes, 
as suggested by Ma and Zeng (2003).
To calculate the MC of an individual-specific molecular 
dataset, the data are first dichotomized according to a par-
ticular gene-specific criterion, followed by mapping of the 
data onto the gene-centric network mentioned above (Fig. 1). 
The dichotomization process defines an individual-specific 
fragmentation of the gene-centric network when nodes (i.e., 
genes) exhibiting one of the two dichotomization states are 
eliminated, and the MC of the dataset is proportional to the 
connectivity of the resulting subnetwork (see “Materials 
and methods”). Calculation of MC thus transforms a high-
dimensional molecular profile into a single quantitative trait 
that can be viewed as a phenotype of the respective indi-
vidual, fit for further analysis such as, for example, classical 
statistical association tests.
In the case of transcriptome data, a natural choice of 
genes to be highlighted comprises those with significantly 
altered expression. This way, MC measures the extent to 
which the co-regulation of gene expression is explicable 




















Fig. 1  The principles of transcriptomic MC analysis. An individual 
expression profile is first dichotomized according to whether each 
gene is ‘saliently’ expressed or not (A). Then, the resulting binary 
signals are mapped onto a gene-centric network (B) that was derived 
earlier from a metabolic network (e.g., Recon 2) according to the 
functional correspondences between genes and proteins (C). Such 
mapping generates a profile specific, effective subnetwork of genes 
connected, or not, by reactions in the original metabolic network (D). 
Finally, the connectivity of the profile-specific subnetwork is calcu-
lated as the proportion of nodes connected to at least one other node 
(i.e., 3/4 in the present case), followed by a z transformation based on 
randomly chosen sets of genes (e)
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network, where ‘adjacency’ means that gene products are 
involved in reactions sharing at least one metabolite. High 
MC can be interpreted as cells responding well to metabolic 
requirements in that gene products in simultaneous need are 
either both abundant or absent. Low MC, in contrast, means 
that the cells are less responsive and somehow ‘ignore’ these 
requirements.
Metabolic coherence was used successfully before to 
assist the interpretation of transcriptome data in the context 
of human disease. Drawing upon a study on pediatric inflam-
matory bowel disease, Knecht et al. (2016) demonstrated 
that the MC of intestinal transcriptomes manifests in two 
distinct types, with different statistical distributions, that 
occur at significantly different prevalence in patients and 
controls. Subsequently, Häsler et al. (2017) showed that tran-
scriptomic MC is associated with disease-related changes in 
human mucosal tissue and microbiome.
So far, however, little is known about the genetic archi-
tecture of transcriptomic MC, i.e., of the number and iden-
tity of the genes that impact upon this trait. Therefore, we 
performed a genome-wide association study (GWAS) of 
transcriptomic MC in an attempt to map quantitative trait 
loci (QTL) that might not only explain the causes of natural 
variation in transcriptomic MC, but that may also contrib-
ute to a better understanding of the abovementioned disease 
associations. Worthy of note, in relating functional (i.e., 
network-based) information to genetic information, we fol-
low Carter et al. (2013) who were among the first to view 
genetic mutations as network perturbations.
Materials and methods
Data characteristics and provenance
The present study drew upon transcriptome and genome 
data from four different human population-based stud-
ies (Table 1). In an exploratory, genome-wide association 
study (GWAS), we used RNA sequencing (RNA-seq) and 
SNP microarray data from the 1000 Genomes/GEUVADIS 
project (Lappalainen et al. 2013) comprising 457 samples 
from five different populations, namely Utah residents with 
Northern and Western European ancestry (CEU, n = 91), 
British (GBR, n = 93), Finns (FIN, n = 94), Tuscans (TSI, 
n = 91) and Yoruba (YRI, n = 88). A total of 241 donors 
(52.7%) were female.
The replication of any significant GWAS findings was 
aimed at in three additional studies for which different types 
of transcriptome and genome data were available, namely 
(1) the German population-based KORA cohort F4 (Koo-
perative Gesundheitsforschung in der Region Augsburg; 
Holle et al. 2005; n = 711, 357 female), (2) US Americans 
of European, non-Hispanic descent from GENOA (Genetic 
Epidemiology Network of Arteriopathy; Daniels et  al. 
2004; n = 411, 233 female, 318 hypertensive) and (3) the 
Dutch BIOS consortium (Biobank-based Integrative Omics 
Study, n = 2661, 1480 female), also including data from the 
Genome of The Netherlands Consortium (Boomsma et al. 
2014).
Transcriptome data
1000 Genomes/GEUVADIS: Gene expression in lympho-
blastoid cell lines (LCL) was quantified by RNA-seq on 
an Illumina HiSeq 2000 as described by Lappalainen et al. 
(2013). For the present study, expression data were down-
loaded from the GEUVADIS website (genome build hg19) 
in the form of RPKM values (Mortazavi et al. 2008), fol-
lowed by log-transformation f(x) = log2(x + 1). Genes with 
raw sequencing counts of zero in > 50% of samples were 
removed, leaving 23,219 genes for subsequent analyses.
KORA: Gene expression in whole blood was quantified 
using the Illumina HT12 v3 microarray. Normalized and 
log-transformed expression data were provided by KORA 
for individuals with matching sex information. Only probes 
with ‘perfect’ or ‘good’ quality according to Barbosa-Morais 
et al. (2010), and with a detection p value < 0.05 in at least 
50% of individuals, were considered further and mapped to 
Ensembl gene identifiers using Bioconductor package illu-
minaHumanv3.db. The resulting dataset comprised 9263 
genes.
Table 1  Description of study data (including cellular origin and molecular typing technology)
Acronym 1000 genomes/GEUVADIS KORA GENOA BIOS
Design Population-based Population-based Hypertensive index patients, siblings (affected and 
non-affected)
Population-based
Population Mixed German US American of European descent (non-Hispanic) Dutch
Sample size 457 711 411 2661
Cell type Lympho-blastoid cell lines Whole blood Lympho-blastoid cell lines Whole blood
Expression data RNA-seq Microarray Microarray RNA-seq
Genetic data Microarray Microarray Microarray Microarray
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GENOA: Gene expression was measured in LCLs from 
818 individuals (hypertension index patients, affected and 
non-affected siblings) using the Affymetrix Human Exon 
1st microarray (Turner et al. 2009). Normalized data were 
downloaded from Gene Expression Omnibus (accession 
number GSE49531; Edgar et al. 2002). For consistency 
reasons, related individuals were excluded, keeping one 
randomly chosen individual per family for further analysis 
(n = 411; 230 affected, 181 non-affected). The final tran-
scriptome dataset comprised 14,701 genes.
BIOS: Gene expression was quantified in whole blood 
by RNA-seq (Illumina HiSeq 2000) as described by Zher-
nakova et al. (2016). Transcriptome data were downloaded 
from the European Genome Phenome Archive (accession 
number EGAS00001001077) in accordance with relevant 
data access regulations. The data were normalized using 
the ‘Median Ratio Method’ as implemented in R package 
DESeq2, and genes with raw sequencing counts of zero in 
> 50% of samples were removed. A total of 21,616 genes 
were included for subsequent analyses.
SNP genotype data
1000 Genomes/GEUVADIS: Genotypes used in the present 
study were generated on an Infinium Omni 2.5M microar-
ray, targeting 2458,634 SNPs. Of the 462 samples for which 
both genotype and expression data were available, five were 
excluded because of inconsistent sex assignment. For the 
457 remaining samples, SNPs were quality-controlled based 
on the following criteria: (1) call rate ≥ 0.99, (2) autoso-
mal location, (3) minor allele frequency (MAF) > 0.05, 
(4) ≥ 5 samples homozygous for the minor allele and (5) 
Hardy–Weinberg equilibrium p ≥ 0.001 both in the YRI 
and in the European subgroups combined. This filtering step 
left 1067,702 SNPs for inclusion in the GWAS. SNP geno-
types were encoded by minor allele dosage. After LD prun-
ing, PCA of the SNP genotypes was carried out to evaluate 
population genetic differences between different populations 
using smartpca from the EIGENSOFT package (version 
6.0.1; Patterson et al. 2006).
KORA: Genotypes imputed from the Affymetrix Human 
Axiom microarray using IMPUTE2 (Howie et al. 2012) 
were provided by KORA (Wichmann et al. 2005). Geno-
type probabilities were converted into minor allele dosage 
format. Some 272 SNPs with MAF ≥ 0.05 were found to be 
located in the 1 Mb region covering the human cadherin 18 
(CDH18) gene and were analyzed in an attempt to replicate 
the main GWAS result.
GENOA: The GENOA participants were genotyped 
on three different SNP microarrays, namely Affymetrix 
AFFY 6.0, Illumina Human660W-Quad v1A and Illumina 
Human1M-Duov3 B. Quality control was carried out as 
described by Daniels et al. (2010). Dosage genotypes for the 
262 SNPs with MAF ≥ 0.05 that were located in the CDH18 
region were provided to us by GENOA under a separate data 
sharing agreement.
BIOS: Samples in BIOS were also genotyped on several 
different SNP microarrays (for details, see Zhernakova et al. 
2016) and the results were processed further using the Geno-
type Harmonizer (Deelen et al. 2014), followed by imputa-
tion using the Michigan imputation server (Das et al. 2016). 
Quality control was carried out as described by Zhernakova 
et al. (2016). Some 246 SNPs from the CDH18 region (MAF 
≥ 0.05) were included in the replication analysis.
Metabolic network coherence (MC)
Transcriptomic metabolic network coherence (henceforth 
referred to as MC, for short) was calculated as described by 
Sonnenschein et al. (2011), with modifications subsequently 
proposed by the same group for human data (Sonnenschein 
et al. 2012). Since MC calculation requires binary input 
(Fig. 1), the gene expression data were dichotomized (‘nor-
mal’ vs ‘salient’) within each study according to whether 
or not a particular expression value belonged to the gene-
specific upper or lower 2% quantile. Both tails of the dis-
tribution were considered simultaneously because our MC 
analysis was geared towards identifying gene pairs with pro-
nounced co-regulation, i.e., comprised both concordant and 
discordant effects. In addition, adoption of the 2% quantile 
was not only found to be a meaningful choice in practice 
before (Knecht et al. 2016), but also represented a viable 
compromise between sensitivity and specificity with regard 
to the detection of salient gene expression.
The connectivity of the profile-specific subnetwork put up 
by the saliently expressed genes was determined by divid-
ing the number of nodes of non-zero degree (i.e., nodes 
connected to at least one other node) by the total number 
of nodes of the subnetwork. The null distribution of the 
connectivity was obtained by simulation (n = 2000), each 
time drawing random gene sets from Recon2 that were of 
the same size as the subnetwork. The MC value of a gene 
expression profile was then defined as its z score with regard 
to the null distribution (Fig. 1). Further details on MC cal-
culation can be found elsewhere (Knecht et al. 2016; Son-
nenschein et al. 2011, 2012).
Calculation of the MC values required mapping of an 
expression profile onto the gene-centric network derived 
from human metabolic model Recon2 (Thiele et al. 2013). 
In the course of this, 5% so-called ‘currency metabolites’ 
(e.g., ATP) were excluded to avoid implausibly short dis-
tances in the ensuing gene-centric network, leaving 1660 
Recon2 genes for further consideration. Of these, 1348 were 
present in the 1000 Genomes/ GEUVADIS transcriptome 
dataset, 896 occurred in KORA, 1302 in GENOA and 1358 
in BIOS. Absent genes were treated as missing in subsequent 
379Human Genetics (2019) 138:375–388 
1 3
analyses (i.e., the gene-centric networks were constructed 
without these genes). Here, ‘absent’ meant that the genes 
in question were either not covered by the respective typ-
ing technology at all or yielded expression values below 
the detection threshold in > 50% of samples, and hence did 
not exhibit sufficient variation for meaningful inclusion in 
the MC calculations. By far the strongest overlap in terms 
of the Recon2 genes present was observed between 1000 
Genomes/GEUVADIS and BIOS (89% concordance). This 
came as no surprise because both datasets were generated 
by RNA sequencing, which is known to be a more sensitive 
and specific means of gene expression analysis than microar-
ray-based typing. Consequently, the remaining concordance 
rates were found to be notably smaller, ranging from 56% for 
GENOA and KORA (different typing technology, different 
tissue) to 72% for 1000 Genomes/ GEUVADIS and GENOA 
(for further details, see Supplementary Figure S1 and Sup-
plementary Table S1). In any case, the observed differences 
in gene content did not cause any notable inter-study differ-
ences in MC value distribution (Supplementary Figure S2).
Sensitivity analysis of the exploratory GWAS was carried 
out varying the percentage of excluded currency metabolites 
from 3 to 8% (in 1% steps) and of the threshold used to define 
salient gene expression from 1 to 3% (in 1% steps). Inter-
population group differences in terms of quantitative vari-
ables were assessed for statistical significance using either a 
Wilcoxon rank sum test (2 groups) or a Kruskal–Wallis test 
(> 2 groups) as implemented in R v.3.4.3.
Genome‑wide association study (GWAS), replication 
and eQTL analysis
Linear models with MC as the continuous response vari-
able and with the minor allele dosage genotype of an SNP 
as an influence variable were employed in the exploratory 
GWAS of the 1000 Genomes/GEUVADIS data. Each model 
included one SNP at a time and was adjusted for population 
affiliation and gender. Additional analyses adjusted for the 
top SNP as well were carried out to search for independ-
ent MC-genotype associations in the respective region. 
Functional annotation of the GWAS summary statistics was 
carried out on the FUMA platform (Watanabe et al. 2017) 
provided by the Complex Trait Genetics (CTG) laboratory 
at VU University Amsterdam, NL.
In our attempt to replicate the sole genome-wide signifi-
cant GWAS signal in the other three studies, between 246 
(BIOS) and 272 (KORA) SNPs located in the CDH18 gene 
region (covering approximately 500 kb upstream and down-
stream of the top SNP) were included in linear models with 
MC as a response variable and the respective dosage geno-
type as an influence variable. The models were adjusted for 
gender (KORA), or gender and biobank source (BIOS), or 
gender, age and hypertension status (GENOA), respectively. 
To correct the significance level for multiple testing, the 
number of LD-effective SNPs in the CDH18 gene region 
was determined using the Genetic Type 1 Error Calculator 
(Li et al. 2012).
A trans-eQTL analysis was performed in 1000 Genomes/ 
GEUVADIS to relate the expression values of the 1348 
Recon2 genes to the genotypes of the SNPs from the CDH18 
gene region. P values from the respective Kruskal–Wallis 
tests were Bonferroni corrected, dividing the nominal sig-
nificance threshold of 0.05 by the product of the number of 
Recon2 genes (n = 1348) and the number of LD-effective 
SNPs (n = 45; see Results).
In an attempt to resolve the MC association of the CDH18 
gene region further and to increase the statistical power of 
the eQTL analysis, we also performed hierarchical cluster-
ing of the dichotomized Recon2 gene expression values 
using R functions dist (method ‘binary’) and hclust (set-
ting ‘ward.D’). The result was subsequently employed to 
divide the Recon2 genes into sub-clusters that efficiently 
reflected the outcome of the eQTL analysis. To this end, 
a threshold to the cluster height was gradually reduced 
until a Kruskal–Wallis test of the gene-specific minimum 
p values from the eQTL analysis indicated nominally sig-
nificant heterogeneity between the emerging sub-clusters 
(Kruskal–Wallis p < 0.05). The sub-cluster with the smallest 
median of the gene-specific minimum p values was then sub-
jected to biological theme enrichment analysis with DAVID 
6.8 (Huang et al. 2009), using default settings. The analysis 
was run against the list of Recon2 genes as background, 
and only enriched terms comprising at least 10 genes were 
considered further.
Results
Principal component analysis (PCA) of the SNP genotypes 
from 1000 Genomes/ GEUVADIS revealed clear differences 
between the African (YRI) and the European ancestry sub-
groups (GBR, FIN, CEU, TSI; Fig. 2). The respective geno-
type clusters were widely separated along the 1st principal 
component (PC), which explained 10.5% of the variance in 
genotype. Differences between European ancestry subgroups 
only became apparent along the 2nd PC, which explained 
0.6% of the variance.
When the metabolic network coherence (MC) values 
derived from the 1000 Genomes/ GEUVADIS transcrip-
tome data were assessed for subgroup heterogeneity using a 
Kruskal–Wallis test, no statistically significant inter-popu-
lation differences were found. However, when the combined 
European ancestry populations were compared to YRI, a 
difference verging on statistical significance became appar-
ent (Wilcoxon test p = 0.067). To reduce the risk of con-
founding, the YRI data were, therefore, excluded from the 
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subsequent GWAS. An additional analysis comprising both 
the YRI and the other 1000 Genomes/ GEUVADIS data was 
performed to check the robustness of the European ancestry-
based results.
A GWAS of the individuals of European ancestry in 
the 1000 Genomes/ GEUVADIS study yielded a single 
genome-wide significant association with MC, located in 
the cadherin18 (CDH18) gene region on human chromo-
some 5 (top SNP: rs11744487, p = 1.2 × 10− 8). As can be 
inferred from the summary Manhattan plot (Fig. 3), no other 
genomic region showed an association with MC of similar 
significance. Moreover, the corresponding QQ-plot (Fig. 4) 
strongly suggests that the test statistics and, hence, the p val-
ues of the GWAS were not systematically inflated. The addi-
tional GWAS also including the YRI subgroup resulted in 
an MC association of the CDH18 gene region that was still 
verging on genome-wide significance (top SNP rs11744487 
p = 5.5 × 10− 8) and, as with the primary GWAS, no other 
signals above random noise were observed (Figs. S3, S4). 
Similarly, the top SNP showed a clear genotype dosage 
effect on MC (Fig. S5) as observed in the European-descent 
populations alone (see below).
The GWAS results were robust to alterations of the pro-
portion of currency metabolites excluded and of the salient 
expression threshold used. Even although p values associ-
ated with the top SNPs were found to vary when the respec-
tive parameters were changed, the qualitative outcome 
remained the same, including the observation of a single 
association signal at the CDH18 gene locus. Further details 
of the GWAS subgroup and sensitivity analyses can be found 
in Supplementary Figure S6 and Supplementary Table S2.
For three SNPs (rs11744487, rs1876591, rs925185) in the 
CDH18 gene region, the association between genotype and 
MC was of genome-wide significance in the primary GWAS 
(p < 5 × 10− 8; Table 2). All three SNPs are located in introns 
of the CDH18 gene. Markers rs925185 and rs1876591 were 
found to be in strong linkage disequilibrium (LD) with each 
other (r2 = 0.98), but in low LD with top SNP rs11744487 
(r2 = 0.24 and r2 = 0.35, respectively). Therefore, they poten-
tially represented a single albeit independent association 
with MC. Moreover, in additional analyses adjusted for the 
top SNP genotype, we detected 41 nominally significant 
MC associations of CDH18 gene SNPs (p < 0.05), one of 
which withstood Bonferroni correction for the number of 
LD-effective SNPs in the region (n = 45, see below). The 












































































































Fig. 2  PCA plot of LD-pruned genome-wide SNP genotype data 
from the 1000 Genomes/GEUVADIS project. Dots were colored 
according to subgroup affiliation. GBR British, FIN Finns, CEU Utah 
residents with Northern and Western European ancestry, YRI Yoruba, 
TSI Tuscans
Fig. 3  Manhattan plot of the primary GWAS of MC (1000 Genomes/ GEUVADIS, European ancestry subgroups only). The red line delineates 
genome-wide significance (i.e., p < 5 × 10− 8)
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at chr5:19677485, some 432 kb upstream of rs11744487 
and 517 kb upstream of rs925185. The second and third 
smallest p values were obtained for the above-mentioned, 
genome-wide significant SNPs rs1876591 (p = 2.6 × 10− 3) 
and rs925185 (p = 2.7 × 10− 3), thereby supporting the con-
clusion that their MC association was largely independent 
of that of the top SNP.
A clear dosage effect on MC was noted for the genotype 
of GWAS top SNP rs11744487 (Fig. 5). While the highest 
median MC value was observed for homozygotes for minor 
allele A, and the lowest for TT homozygotes, AT heterozy-
gotes showed intermediate MC.
In the 1  Mb region surrounding the CDH18 gene 
(chr5:19600000–chr5:20600000), 280 SNPs passed quality 
control in the 1000 Genomes/ GEUVADIS data (Fig. 6). 
The number of LD-effective SNPs in the region, as cal-
culated from the same dataset, equaled 45. Based on the 
results of the primary GWAS, these 280 SNPs were chosen 
for replication of the putative MC association in the KORA, 
GENOA and BIOS studies. Notably, functional annotation 
of the target region with FUMA revealed the presence of 
two long non-coding RNAs (lncRNAs; ENSG00000214132, 
ENSG00000248766) and one antisense RNA (CDH18-AS1).
Replication of the GWAS results failed in the KORA 
and GENOA studies in that neither rs11744787 nor any of 
the other SNPs in the CHD18 gene region was significantly 
associated with MC (for further details, see Supplemen-
tary Figs. S7 and S8). In contrast, two SNPs (rs4866180, 
p = 4.6 × 10− 4; rs6884961; p = 4.8 × 10− 4) showed a statisti-
cally significant association in the BIOS study after Bonfer-
roni correction for the number of LD-effective SNPs in the 
region (i.e., p < 0.001; Fig. 7; Table 2). These two SNPs 
were found to be in strong linkage disequilibrium with each 
other (r2 = 0.92), but not with rs11744487 (r2 = 0.01 for both 
rs4866180 and rs6884961). Notably, their association with 
MC was also verging on nominal significance in the 1000 
Genomes/ GEUVADIS dataset (p = 0.061 for rs4866180, 
p = 0.072 for rs6884961). For a meta-analysis highlighting 
the robustness of the associations between MC and SNPs 
from the CDH18 gene region, see Supplementary Table S3.
Closer inspection of the region showed that both SNPs 
are located at the center of antisense RNA CDH18-AS1, 
some 200 kb downstream of the GWAS top SNP (Fig. 7). 
Moreover, consultation of the Genotype-Tissue Expression 
(GTEx) database (The GTEx Consortium 2013) revealed 
that both SNPs act as cis-eQTLs of CDH18-AS1 in human 
testis, but not in brain (the other tissue in which the antisense 
RNA is expressed in human adults).
A trans-eQTL analysis of the 1348 Recon2 genes and 
the 280 SNPs from the CDH18 gene region was carried 
out in the 1000 Genomes/ GEUVADIS dataset (European 
ancestry only) to elucidate whether the observed GWAS 
signal could be attributed to associations between the 
genotypes of particular SNPs and the expression levels of 
particular genes. However, while multiple SNP-specific 
use of a Kruskal–Wallis test revealed at least one nomi-
nally significant genotype-expression level association 
(p < 1.1 × 10− 3=0.05/45 upon correction for the number of 
LD-effective SNPs) for 96 genes (7.3% of Recon2 genes), 
none of these results withstood additional Bonferroni cor-
rection for the number of Recon2 genes tested (n = 1348; i.e., 
p < 8.2 × 10− 7). For a detailed summary of the results of the 
eQTL analysis, see Supplementary Table S4.
Fig. 4  QQ plot of p values from the primary GWAS of MC (1000 
Genomes/GEUVADIS, European ancestry subgroups only)
Table 2  Statistically significant associations between MC and CDH18 gene SNPs
MAF minor allele frequency
Study SNP Location (bp) Minor allele Major allele MAF GWAS p value
1000 Genomes/GEUVADIS, 
European ancestry
rs11744487 chr5:20109561 A T 0.49 1.2 × 10− 8
rs1876591 chr5:20201563 C G 0.49 1.5 × 10− 8
rs925185 chr5:20194982 T A 0.48 2.8 × 10− 8
BIOS rs4866180 chr5:20328064 C G 0.45 4.6 × 10− 4
rs6884961 chr5:20325180 G C 0.46 4.8 × 10− 4
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The dichotomized expression values used for MC calcu-
lation (see Materials and Methods) were also subjected to 
hierarchical cluster analysis (Fig. 8) and the outcome was 
employed for a decomposition of the Recon2 genes into 
sub-clusters, based on the results of the eQTL analysis. To 
this end, the dendrogram height defining the number and 
identity of sub-clusters was gradually reduced. Each time 
when a sub-cluster was split into two new sub-clusters, a 
Kruskal–Wallis test was performed for the gene-specific 
minimum eQTL p values obtained in the CDH18 gene 
region (see also Supplementary Table  S4). The tests 
yielded a nominally significant result for four sub-clusters 
(p = 0.035; Fig. 8), but not for two (p = 0.105) or three sub-
clusters (p = 0.171). Of the four sub-clusters, numbers 1 
(72 genes) and 3 (84 genes) were characterized by a lower 
median p value (7.7 × 10− 3 and 7.5 × 10− 3, respectively) than 
Fig. 5  Dosage effect of 
rs11744487 genotype on MC in 
the 1000 Genomes/ GEU-
VADIS data (European ancestry 
only). Genotypes are encoded as 
0: AA, 1: AT, 2: TT
Fig. 6  Locus zoom plot 
of GWAS results from the 
1000 Genomes/GEUVADIS 
data (European ancestry 
only). Depicted is the 1 Mb 
region around the CDH18 
gene (chr5:19600000–
chr5:20600000, based on 
hg19). The location of antisense 
RNA CDH18-AS1 is marked 
by a horizontal blue line 
whereas the lincRNA posi-
tions are indicated by squares 
(ENSG00000214132: green, 
ENSG00000248766: red). 
The top SNP (rs11744487) is 
highlighted in purple. Linkage 
disequilibrium is color-coded 
(red to blue) according to r2 
with the top SNP
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numbers 2 (9.5 × 10− 3; 672 genes) and 4 (9.6 × 10− 3; 519 
genes).
Analysis with DAVID 6.8 (Huang et al. 2009) yielded 23 
biological terms that were found to be significantly enriched 
in sub-cluster 3 (p < 0.05 after Bonferroni correction; 
Table 3); no significantly enriched terms were reported for 
sub-cluster 1. The lowest enrichment p values were obtained 
for genes in sub-cluster 3 that are associated with KEGG 
terms related to neurodegenerative diseases (Huntington, 
Parkinson, Alzheimer), followed by several terms broadly 
related to energy metabolism and mitochondrial function.
Discussion
We identified a single, genome-wide significant association 
between sequence variation at a particular gene locus and 
the metabolic coherence (MC) of human transcriptomes. 
Fig. 7  Locus-zoom plot of 
MC-SNP associations in 
the BIOS data. Depicted is 
the 1 Mb region around the 
CDH18 gene (chr5:19600000–
chr5:20600000, based on 
hg19). The location of antisense 
RNA CDH18-AS1 is marked 
by a horizontal blue line, 
whereas the lincRNA posi-
tions are indicated by squares 
(ENSG00000214132: green, 
ENSG00000248766: red). Both 
the top SNP from the replication 
analysis (rs4866180) and the top 
SNP from the primary GWAS 
(rs11744487) are highlighted in 
purple. Linkage disequilibrium 
is color-coded (red to blue) 
according to  r2 with the top SNP 
from the replication analysis
Fig. 8  Cluster analysis of 
Recon2 gene expression levels 
in 1000 Genomes/GEUVADIS. 
The original RNA-seq data 
were dichotomized according 
to whether or not a particular 
expression value belonged 
to the gene-specific upper or 
lower 2% quantile in the 1000 
Genomes/ GEUVADIS data. 
The four sub-clusters, color 
coded at the bottom of the 
dendrogram, were defined by 
reference to the gene-specific 
minimum p values obtained in 
a trans-eQTL analysis of the 
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The associated SNPs were located in the intronic region of 
the cadherin 18 (CDH18) gene on chromosome 5. This is a 
remarkable finding because GWAS of complex phenotypes 
usually lack such solitary and distinct signals but yield a 
number of significant associations instead, depending on the 
sample size as well as the genetic architecture and heritabil-
ity of the trait under study. Although the 1000 Genomes/
GEUVADIS sample was small compared to other recent 
GWAS, the peculiar distribution of p values observed in 
our study is not explicable by dearth of power alone. A lack 
of power would have resulted in a genome-wide gradient of 
signals, some of borderline statistical significance, rather 
than one protruding signal. Therefore, we have good rea-
son to believe that the genome-wide significant association 
observed with MC points towards a genuine involvement of 
the CDH18 gene locus in metabolic processes, at least as far 
as the expression of metabolism-relevant genes included in 
the Recon2 model is concerned.
Cadherin 18, previously termed cadherin 14, was first 
described by Shibata et al. (1997). It belongs to the large 
cadherin superfamily, a class of calcium-dependent trans-
membrane proteins encoded by more than 100 genes 
(classical cadherins and related genes), many of which are 
organized in clusters. The cluster containing the CDH18 
gene is located on human chromosome 5 (5p14-15, 5q13-15 
and 5q31-32) and deletions in this region have been linked 
to an increased risk of developing different diseases (Kaji-
kawa et al. 2011; Zhang et al. 2013). Cadherins mediate 
cell–cell adhesion and play a vital role in tissue homeostasis 
and in morphogenesis (Leckband and Sivasankar 2012). For 
example, they regulate neural tube regionalization, neuronal 
migration, gray matter differentiation, neural circuit forma-
tion, spine morphology, synapse formation and synaptic 
plasticity (Redies et al. 2012). Furthermore, cadherins are 
also involved in intracellular signaling pathways.
Classical vertebrate cadherins are subdivided into type 
1 and type 2, based on the presence of a histidine–ala-
nine–valine motif in the first extracellular domain. Type 1 
cadherins, which comprise some of the best characterized 
members of this class of proteins, are typically segregated 
by the embryonic germ layer or tissue type (Shapiro and 
Weis 2009). Type 2 cadherins like CDH18, in contrast, are 
less well characterized and exhibit more complex expres-
sion patterns, often associated with the developing neuronal 
Table 3  Biological theme enrichment analysis of 84 Recon2 genes with low minimum p values in a trans-eQTL analysis of the CDH18 gene 
region (sub-cluster 3 in Fig. 8)
 aNumber of Recon2 genes associated with the term in an enrichment analysis with DAVID 6.8 (Huang et al. 2009)
b p values were Bonferroni corrected for the number of functional terms tested
Category Term No. genes (%)a Enrichment p  valueb
KEGG_PATHWAY hsa05016: Huntington’s disease 34 (40) 1.2 × 10− 19
KEGG_PATHWAY hsa05012: Parkinson’s disease 33 (39) 1.9 × 10− 17
KEGG_PATHWAY hsa05010: Alzheimer’s disease 32 (38) 2.7 × 10− 17
GOTERM_CC_DIRECT GO:0005743 ~ mitochondrial inner membrane 39 (46) 3.5 × 10− 16
UP_KEYWORDS Acetylation 61 (73) 8.6 × 10− 16
UP_KEYWORDS Mitochondrion inner membrane 34 (40) 1.3 × 10− 15
KEGG_PATHWAY hsa00190: oxidative phosphorylation 34 (40) 1.5 × 10− 15
UP_KEYWORDS Mitochondrion 50 (60) 1.4 ×10− 13
UP_KEYWORDS Respiratory chain 21 (25) 1.9 × 10− 11
UP_KEYWORDS Electron transport 22 (26) 1.7 × 10− 10
KEGG_PATHWAY hsa04932: non-alcoholic fatty liver disease (NAFLD) 24 (29) 2.9 × 10− 10
GOTERM_MF_DIRECT GO:0008137 ~ NADH dehydrogenase (ubiquinone) activity 16 (19) 4.2 × 10− 8
GOTERM_CC_DIRECT GO:0005747 ~ mitochondrial respiratory chain complex I 16 (19) 2.5 × 10− 8
GOTERM_CC_DIRECT GO:0005739 ~ mitochondrion 45 (54) 2.6 × 10− 8
GOTERM_BP_DIRECT GO:0032981 ~ mitochondrial respiratory chain complex I assembly 16 (19) 1.6 × 10− 7
GOTERM_BP_DIRECT GO:0006120 ~ mitochondrial electron transport. NADH to ubiquinone 16 (19) 2.3 × 10− 7
GOTERM_MF_DIRECT GO:0044822 ~ poly(A) RNA binding 12 (14) 3.0 × 10− 5
UP_KEYWORDS Transit peptide 29 (35) 3.9 × 10− 5
UP_SEQ_FEATURE Transit peptide: mitochondrion 28 (33) 6.3 × 10− 5
GOTERM_CC_DIRECT GO:0043209 ~ myelin sheath 14 (17) 5.4 × 10− 5
UP_KEYWORDS Ubiquinone 11 (13) 2.3 × 10− 4
UP_KEYWORDS Transport 36 (43) 1.3 × 10− 3
GOTERM_CC_DIRECT GO:0070062 ~ extracellular exosome 41 (49) 7.6 × 10− 3
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system (Bekirov et al. 2002). Knockout of cadherin genes 
often leads to separation of cells or disrupts tissue architec-
ture (Hirano and Takeichi 2012). On the other hand, over-
expression of cadherin genes is frequently associated with 
the development of malignant tumors (Suyama et al. 2002). 
Noteworthy in the context of the present study, differential 
expression of cadherin genes has been observed in diseases 
with a metabolic component as well. For example, Burke 
et al. (2011) described upregulation of N-cadherin in fibro-
blasts from patients with Crohn disease, causing decreased 
wound-healing capacity and increased fibroblast migration. 
Similarly, a mutation in the E-cadherin gene was found to 
be associated with an increased risk of developing Crohn 
disease in the first place (Muise et al. 2009).
Cadherin 18 is expressed in various tissues, but appears 
to be confined mainly to the central nervous system (CNS; 
Bekirov et al. 2002). Consequently, CDH18 gene expression 
itself was too low for reliable quantification in the datasets 
available for our study because the data were generated 
from either LCLs (1000 Genomes/ GEUVADIS, GENOA) 
or whole blood (KORA, BIOS). Since cadherin 18 is also 
not included in the Recon2 network, we suspect that the 
observed association between variation at the CDH18 
gene locus and MC is not due to any current activity of 
the cadherin 18 protein but involves other mechanisms, pos-
sibly during neuronal development, that govern metabolic 
processes in later life. In previous GWAS, variants of the 
CDH18 gene were found to be associated with leprosy (Liu 
et al. 2015), age-related hearing impairment (Fransen et al. 
2015), blood pressure-related traits in African-Americans 
(Liang et al. 2017) and with obesity in adult survivors of 
childhood cancer (Wilson et al. 2015). The last finding in 
particular suggests a role of the CDH18 gene locus in body 
composition, with possible metabolic consequences during 
adulthood.
In a linkage study of adiponectin serving as a surrogate 
for metabolic syndrome, Comuzzie et al. (2001) identified 
genome-wide significant genetic linkage with the wider 
CDH18 gene region at 5p14. Later, Zhang et al. (2013) 
explored the local effects further by fine mapping and dis-
covered that several SNPs in the intronic region of CDH18 
were significantly associated with metabolic syndrome-
related traits, including weight, BMI and waist circumfer-
ence. The authors speculated that these associations were 
due to cell–cell adhesion processes, mediated by cadherin 
18, with a direct impact upon the deposition of visceral 
abdominal fat reserves. Another possible explanation pro-
vided by Zhang et al. (2013) was a role of cadherin 18 in 
body development and body composition driven by the CNS 
during embryonic development.
A focused eQTL analysis in our study did not reveal any 
statistically significant associations between SNPs in the 
CDH18 gene region and the expression of particular genes 
in Recon2, which implies that the genotypic association with 
MC that emerged in 1000 Genomes/ GEUVADIS and BIOS 
is not attributable to a small number of genes. This notwith-
standing, when the Recon2 genes were clustered according 
to their degree of salient expression in the 1000 Genomes/
GEUVADIS samples, those genes with the strongest asso-
ciation to variation at the CDH18 locus were enriched for 
links to either neurodegenerative diseases or mitochondrial 
function. While the former clearly lends additional support 
to the hypothesis that the observed MC-CDH18 association 
is driven by neurophysiological processes, the latter find-
ing suggests that the downstream consequences of these 
processes may indeed include modifications of the energy 
metabolism in later life.
It must be emphasized here that the biological phenom-
enon underlying the GWAS signal detected in the 1000 
Genomes/GEUVADIS and BIOS data, although not yet 
fully understood, would have gone unnoticed in a non-net-
work-based eQTL analysis, particularly when carried out 
at genome-wide level and in moderately sized samples like 
those used in the our study. This outcome not only recalls the 
view of Carter et al. (2013) that many mutations exert their 
biological effects via network perturbation, but also high-
lights the potential benefit of adopting system-orientated 
approaches to molecular data analysis in general. They usu-
ally exploit the richness of data more comprehensively than 
classical analysis techniques and take the scientific value of 
the data themselves to a higher level by contextualizing them 
with external biological knowledge.
Prior to our validation analysis, we were concerned 
that replication of any potential GWAS signal from 1000 
Genomes/GEUVADIS might fail in other studies if differ-
ent cell types were used to measure gene expression. Whilst 
the 1000 Genomes/GEUVADIS and GENOA data were 
obtained from LCLs, KORA and BIOS used whole blood 
samples (Table 1). Indeed, the Epstein–Barr virus (EBV) 
transformation of LCLs is known to affect the expression 
of a number of genes, including those encoding cadherins 
(Breitfeld et al. 2016; Murakami et al. 2005), but because 
replication of the GWAS signal was successful in BIOS, not 
GENOA, EBV transformation can be ruled out as a cause 
of the observed discrepancies. Instead, it appears as if the 
technology used for expression analysis was more critical: 
In 1000 Genomes/GEUVADIS and BIOS, transcriptome 
data were generated by RNA-seq whereas microarrays were 
used in KORA and GENOA. Microarrays provide much 
lower genome coverage than RNA-seq, which in turn leads 
to a poorer representation of Recon2 genes in the datasets. 
Hence, the failed validation in KORA and GENOA may 
simply reflect a detection problem and the greater power of 
RNA-seq may be required to yield biologically meaningful 
results when applying network-based dimensionality reduc-
tion, such as MC, to whole transcriptome data.
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Interestingly, top SNPs rs4866180 and rs6884961 from 
the successful replication analysis in BIOS are located in 
the center of an antisense RNA (CDH18-AS1). Moreover, 
both SNPs were found in GTEx to act as cis-eQTLs for 
CDH18-AS1 in humans. Although this effect was limited to 
testis, the only adult tissue apart from brain where CDH18-
AS1 is expressed, our observation nevertheless suggests 
that CDH18 gene variation may also play a regulatory role 
in other tissues during early human development as well. 
Hence, we are currently planning further laboratory experi-
ments to determine if and how knockout or overexpression 
of cadherin 18 and CDH18-AS1 may impact upon metabolic 
processes in vitro.
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